New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

New York City-based Memorial Sloan Kettering Cancer Center has unified its Epic EHR so its patients, providers, researchers and labs are all on the same system. Here are six things to know from an Aug ...

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

The American Cancer Society (ACS) has awarded The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai a $4.08 million grant to establish the Cancer Health Research Center at Mount ...

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical study of its novel nectin-4-targeting ...

Kelley Mack, an actor who starred in "The Walking Dead," died due to complications from the COVID-19 vaccine. Actor Kelley ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results ...

Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...

Because work, at its simplest, is fundamentally enjoyable! We don’t get paid because work is painful. We get paid because we ...